Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: FDA has Approved Skinvive by Juvéderm
In today's Pharmaceutical Executive Daily, Elicio Therapeutics shares tumble after its Phase II Amplifgy-7P trial of KRAS-targeting immunotherapy ELI…
5 months ago
Pharmaceutical Executive Daily: FDA Approves Two Indications of Keytruda in Combination with Welireg
In today's Pharmaceutical Executive Daily, Boehringer Ingelheim's Brian Hilberdink argues that obesity innovation must evolve beyond the scale, a pha…
5 months ago
Pharmaceutical Executive Daily: Kardigan Sets Terms for $350 Million IPO
In today's Pharmaceutical Executive Daily, Kardigan sets terms for a $350 million IPO that would value the cardiovascular biotech at approximately $1…
5 months ago
Pharmaceutical Executive Daily: China's Latest Policy Guidance
In today's Pharmaceutical Executive Daily, Bruce Liu examines China's latest policy guidance establishing premium pricing and priority reimbursement …
5 months, 1 week ago
Pharmaceutical Executive Daily: Parabilis Medicines Prices Record-Breaking $670 Million IPO
In today's Pharmaceutical Executive Daily, Parabilis Medicines prices a record-breaking $670 million IPO, Swedish biotech AlzeCure Pharma enters a co…
5 months, 1 week ago
The Ron Lanton Report: From Innovation to Infrastructure
In this episode, Ron Lanton draws on insights from the JP Morgan Healthcare Conference to explain how healthcare investment is shifting from backing …
5 months, 1 week ago
Pharmaceutical Executive Daily: GSK Acquires Nuvalent for $10.6 Billion
In today's Pharmaceutical Executive Daily, a pharma funding roundup covers two RNA-focused biotechs that secured fresh capital, GSK announces a $10.6…
5 months, 1 week ago
Pharmaceutical Executive Daily: Roche and Nurix Therapeutics Announce Global Collaboration
In today's Pharmaceutical Executive Daily, Roche and Nurix Therapeutics announce a global collaboration, a pharma M&A roundup covers three deals anno…
5 months, 1 week ago
Pharmaceutical Executive Daily: Supreme Court Unanimously Rules in Favor of Hikma Pharmaceuticals in Skinny Label Case
In today's Pharmaceutical Executive Daily, the Supreme Court unanimously rules in favor of Hikma Pharmaceuticals in its patent dispute with Amarin ov…
5 months, 1 week ago
Pharmaceutical Executive Daily: Alnylam Pharmaceuticals and Inceptive Nucleics Announce 3 Year Strategic Collaboration
In today's Pharmaceutical Executive Daily, Eli Lilly escalates its 340B enforcement standoff by notifying covered entities of a five-business-day win…
5 months, 2 weeks ago